Machine learning from the CARDAMON trial identifies a carfilzomib-specific mutational response signature

Ieuan G Walker, Venetia D’arcy, Garima Khandelwal, Georgina Anderson, Anna Aubareda, William Wilson, Evelyn Fitzsimons, Daria Galas-Filipowicz, Kane Foster, Rakesh Popat, Karthik Ramasamy, Matthew Streetly, Ceri Bygrave, Reuben Benjamin, Ruth M. de Tute, Marquita Camilleri, Selina J Chavda, Gavin Pang, Tushhar Dadaga, Sumaiya Kamora, James Cavenagh, Elizabeth H. Phillips, Laura Clifton-Hadley, Roger G Owen, Javier Herrero, Kwee Yong, Michael A Chapman
doi: https://doi.org/10.1101/2023.04.08.23288287

Article usage

Article usage: April 2023 to June 2025

AbstractFullPdf
Apr 20234481147
May 202394116
Jun 202380511
Jul 202358112
Aug 202331129
Sep 202333411
Oct 20233848
Nov 20231916
Dec 20232917
Jan 202418110
Feb 20242416
Mar 202446314
Apr 202421518
May 20242168
Jun 20242768
Jul 202427812
Aug 20241927
Sep 20243859
Oct 20241515
Nov 20241519
Dec 20241543
Jan 20253189
Feb 202511175
Mar 2025453212
Apr 2025391718
May 2025371518
Jun 2025510
Back to top
Posted April 09, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Machine learning from the CARDAMON trial identifies a carfilzomib-specific mutational response signature
Ieuan G Walker, Venetia D’arcy, Garima Khandelwal, Georgina Anderson, Anna Aubareda, William Wilson, Evelyn Fitzsimons, Daria Galas-Filipowicz, Kane Foster, Rakesh Popat, Karthik Ramasamy, Matthew Streetly, Ceri Bygrave, Reuben Benjamin, Ruth M. de Tute, Marquita Camilleri, Selina J Chavda, Gavin Pang, Tushhar Dadaga, Sumaiya Kamora, James Cavenagh, Elizabeth H. Phillips, Laura Clifton-Hadley, Roger G Owen, Javier Herrero, Kwee Yong, Michael A Chapman
medRxiv 2023.04.08.23288287; doi: https://doi.org/10.1101/2023.04.08.23288287
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area